- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
2020 promises to be a big one for health care. Cutting drug prices is a top priority for both the Democratic House and the White House. CMS' innovation center has controversial demos in store. Obamacare is at a crossroads after a federal judge deemed the entire law invalid. Medicaid expansion and work requirements will continue to be lightning rods in statehouses and courthouses around the country. And FDA continues to crank out new policies for regulating emerging technologies.
© 2002-2023. Inside Washington Publishers | Contact Us